产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 现货 | |||
| 5mg | 99% | 现货 | |||
| 10mg | 99% | 现货 | |||
| 25mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 | |||
| 250mg | 99% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 现货 | |||
| 5mg | 99% | 现货 | |||
| 10mg | 99% | 现货 | |||
| 25mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 | |||
| 250mg | 99% | 现货 |
CAS No. |
133-04-0 |
|---|---|
中文名称 |
(1R,3aS,4S,6aS)-1,4-双(苯并[d][1,3]二氧戊环-5-基)四氢-1H,3H-呋喃并[3,4-c]呋喃 |
英文名称 |
(1R,3aS,4S,6aS)-1,4-Bis(benzo[d][1,3]dioxol-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan |
别名 |
EDTA disodium calcium salt | 1,3-Benzodioxole,5,5'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis- | 5,5'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis-1,3-benzodioxole | CCRIS 8100 | AC-34863 | Q27256222 | (1RS,3aRS,4SS |
标准英文名 |
(1R,3aS,4S,6aS)-1,4-bis(benzo[d][1,3]dioxol-5-yl)tetrahydro-1H,3H-furo[3,4-c]furan |
MDL No. |
MFCD00198067 |
分子式 |
C20H18O6 |
分子量 |
354.36 |
精确分子量 |
354.11 |
SMILES |
[H][C@]12[C@](CO[C@@H]2C3=CC=C(OCO4)C4=C3)([H])[C@H](C5=CC=C(OCO6)C6=C5)OC1 |
标准SMILES |
C1O[C@@H]([C@@H]2CO[C@H]([C@@H]21)C1C=C2OCOC2=CC=1)C1C=C2OCOC2=CC=1 |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
PEYUIKBAABKQKQ-FQZPYLGXSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral,Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|